Xeris Biopharma Holdings, Inc. XERS
15.36 USD -0.50 (-3.18%)
Nov 10, 2026, 2:05 PM EST
15.22 Day range 16.11
5.25 52-week range 16.11
- YTD
- +95.61%
- 1 year
- +98.90%
Financial health
Altman Z-Score
3.77 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
5 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
Rating
D+1 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1